New drug cocktail shows promise in battle against head and neck cancer
Disease control
Not yet recruiting
This study tests whether combining the immunotherapy drug camrelizumab with either an EGFR antibody or chemotherapy can help people with advanced head and neck cancer live longer. About 246 adults with stage III or IV cancer will receive the treatment before and after surgery. Th…
Phase: PHASE3 • Sponsor: Yue He, MD • Aim: Disease control
Last updated Apr 29, 2026 03:41 UTC